FAQs in MS: Exploring Provocative Questions From MS Meeting Updates
March 27, 2023
March 27, 2024
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Genentech, Inc.
- Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)™
- Nurses — 0.75 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is directed toward MS specialists, community neurologists, neuroimmunologists, specialty NPs, PAs, RNs, and other members of the MS care team.
The PER FAQ™ is an innovative video-based activity that features a clinical expert answering questions submitted by learners who participated in a related PER Postgame™ activity. It is intended to provide useful commentary about important research-related or point-of-care focused questions that many clinicians face in daily practice. This activity is based on the PER Postgame™ activity, MS Meeting Updates: Integrating the Latest Data to Optimize Care in the COVID-19 Era, that reviews abstracts that were presented at relevant 2022 annual MS meetings regarding emerging biomarkers, clinical trial data for current and emerging disease-modifying therapies, and the impact of COVID-19 on MS management decisions.
Upon completion of this activity, participants should be better able to:
- Describe currently available molecular biomarkers/other key indicators of MS and their role in early differential diagnosis and monitoring disease progression
- Evaluate recent efficacy and safety data of current and emerging DMTs for the optimal treatment of patients with MS
- Discuss the impact of DMTs on anti-SARS-CoV-2 vaccine response in patients with MS
Joseph J. Sabatino Jr., MD, PhD
Department of Neurology
Weill Institute for Neurosciences
University of California, San Francisco
San Francisco, CA
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.75 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.
- Joseph J. Sabatino Jr., MD, PhD
- Grant/Research Support: Novartis Pharmaceuticals; Roche-Genentech
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
You may immediately download your certificate.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.